A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial) - Concepedia

Concepedia

Publication | Open Access

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)

DOI Full Paper Access

111

Citations

25

References

2019

Year

Joel M. Gelfand, Daniel B. Shin, Abass Alavi, Drew A. Torigian, Tom Werner, Maryte Papadopoulos, Junko Takeshita, Megan H. Noe, Amit K. Dey, Martin P. Playford,

Journal of Investigative Dermatology

References

	Year	Citations

Page 1